Drug Profile
Nomegestrol oral
Alternative Names: Lutenil; Lutenyl; NOMAC; Nomegestrol acetate oral; TX 066Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Theramex SAM
- Developer Theramex; Theramex SAM
- Class Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Menorrhagia; Uterine diseases
- No development reported Breast cancer; Pregnancy
Most Recent Events
- 01 Feb 2018 Teva Women's Health was sold by Teva Pharmaceuticals to CVC Capital Partners, to create an international pharmaceutical company dedicated to Women’s Health named Theramex
- 30 Sep 2011 Nycomed has been acquired by Takeda
- 06 Jan 2011 Theramex SAM has been acquired by Teva Pharmaceutical Industries